It would have been interesting to have sat in on the senior management meetings at Merck that thrashed out the Organon ...

Thank you for joining Organon's first quarter earnings call ... Renflexis and Hadlima are mainly supplied from Korea and the EU. For recently acquired Tofidence, that product is manufactured in China, ...

Organon (OGN) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

Prior to Avtozma, the FDA approved two other Actemra biosimilars: Tofidence (tocilizumab-bavi) in September 2023 and Tyenne (tocilizumab-aazg) in March 2024. The introduction of Avtozma adds to the ...

In another development, Organon has acquired the U.S. rights to TOFIDENCE™, a biosimilar to ACTEMRA®, from Biogen, further expanding its arthritis treatment portfolio. Furthermore, Biogen plans to ...

Galderma has kicked off an ad campaign to show how its Nemluvio can empower people to rule over itchy eczema. Aiming to grow the biologic into a $2 billion product, the company is running ads ...

In another development, Organon has acquired the U.S. rights to TOFIDENCE™, a biosimilar to ACTEMRA®, from Biogen, further expanding its arthritis treatment portfolio. Furthermore, Biogen plans ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...